Cost-Effectiveness Analysis of Abrocitinib Compared with Dupilumab for Adolescents With Severe Atopic Dermatitis in Spain.

ABSTRACT:

SUBMITTER: Romero Jimenez RM 

PROVIDER: S-EPMC12796019 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature